D. E. Shaw & Co., Inc. Kaleido Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.3 - $2.7 $24,475 - $50,832	-18,827 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $44,996 - $113,338	18,827 New	18,827 $45,000
Q3 2021 Nov 15, 2021	SELL	$5.36 - $7.99 $56,188 - $83,759	-10,483 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.82 - $8.72 $61,011 - $91,411	10,483 New	10,483 $78,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.